Insmed Inc. buy Guggenheim
Start price
10.07.26
/
50%
€100.44
Target price
10.07.27
€180.75
Performance (%)
12.94%
Price
06.08.26
€86.03
Summary
This prediction is currently active. The prediction currently has a performance of 12.94%. This prediction currently runs until 10.07.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Insmed Inc. | -1.680% |
| iShares Core DAX® | 2,57 % |
| iShares Nasdaq 100 | 4,86 % |
| iShares Nikkei 225® | 5,59 % |
| iShares S&P 500 | 3,25 % |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its "buy" rating reaffirmed by Guggenheim. They now have a $207.00 price target on the stock.
Ratings data for INSM provided by MarketBeat

